Find an expert

Liam is an Associate Professor in Telehealth and Director of Telehealth Technology for the University of Queensland’s Centre for Online Health.

Liam has a PhD in Medicine. His research is centred on pragmatic trials of telehealth services. Liam has a special interest in the use of telehealth for Indigenous health and rural health care delivery. He is involved in telehealth service development, delivery and evaluation across a broad range of telehealth services. Liam uses implementation research principles to understand why telehealth services work well in some scenarios and not others. He evaluates the effectiveness of telehealth from multi-disciplinary perspectives including clinical effectiveness, patient perspectives, economic aspects, organisational aspects, and socio-cultural, ethical and legal aspects.

Liam also has an active research agenda in health informatics, in particular, in imaging informatics. Liam’s work focusses on skin imaging for melanoma detection. Liam chairs dermatology working group for the DICOM standards development organisation as well as the technology standards working group for the International Skin Imaging Collaboration: Melanoma Project. This project is an academia and industry partnership designed to facilitate the application of digital skin imaging to help reduce melanoma mortality. Liam is technology lead for the Australian Centre of Excellence in Melanoma Imaging and Diagnosis. Liam has previously been a member of the Standards Australia IT-014 Health Informatics technical committees for telehealth and messaging and communication.

Liam is Vice-President of the Australian Telehealth Society and an executive member of the International Teledermatology Society.

Liam has 25 years industry experience as a health informatician. His immediate past role was the Manager of Medical Imaging Informatics at the Royal Brisbane and Women’s Hospital. Previously, Liam had over a decade’s clinical experience as a diagnostic radiographer.

Professor John Cairney is the Head of School of Human Movement and Nutrition Sciences. He is an academic leader in the field of paediatric exercise medicine and child health research and is particularly well-known for his work on developmental coordination disorder (DCD) and its impact on the health and well-being of children. Prof John Cairney started at UQ in January 2020.

Until the end of 2019, he was the Director of Graduate Studies in the Faculty of Kinesiology and Physical Education at the University of Toronto and Director of the Infant and Child Health (INCH) Research Laboratory at both the University of Toronto and McMaster University. He is also an Adjunct Professor in the Departments of Public Health Sciences and Psychiatry at the University of Toronto and Department of Family Medicine at McMaster University and a core scientist with the Offord Centre for Child Studies, CanChild Centre for Childhood Disability Research at McMaster University, and the independent Institute for Clinical Evaluative Sciences.

Professor Cairney completed his PhD studies at the University of Western Ontario and has held academic appointments at Brock University, the University of Toronto and McMaster University before his current UQ role. He has held, among other research leadership positions, a Canada Research Chair in the Department of Psychiatry at the University of Toronto, and a Professorship in Child Health, and subsequently a Research Chair, in the Department of Family Medicine at McMaster University.

Professor Cairney has been the recipient of ~$A17 million in research grants as a principal investigator and has some 310 published works with a Scopus h index of 51 (Aug 2022).

Professor Cairney is a former President of the North American Society of Pediatric Exercise Medicine.

Professor Leonie Callaway is an Obstetric Physician, with a strong track record in clinical research relating to gestational diabetes, hypertension in pregnancy, medical disorders of pregnancy, clinical trials, clinical studies and epidemiology. Research funding to date has totalled in excess of 12 million dollars. This includes funding for a number of clinical trials and clinical studies as Chief Investigator supported by both the NH&MRC and the Medical Research Futures Fund.

Prof Callaway has a long track record of successful PhD scholar supervision. She has a particular interest in the issues of work life balance and wellbeing for scholars undertaking research higher degrees.

At present, Prof Callaway holds a number of roles including Director of Research within Women’s and Newborn Services at the Royal Brisbane and Women’s Hospital, Executive Director of the Women’s and Children’s Stream for Metro North Hospital and Health Service District and Co-Chair of the Queensland Maternal and Perinatal Quality Council. This work has been supported by qualifications in Executive Leadership and as a Company Director.

Prof Callaway’s past leadership experience is broad, and includes the domains of clinical education, health service delivery and research. Previous roles include Chair of the Board of the Australasian Diabetes in Pregnancy Society, Deputy Dean of the School of Medicine at the University of Queensland, Acting Director of Internal Medicine Services at Royal Brisbane and Women’s Hospital and Head of the Royal Brisbane Clinical School for the University of Queensland.

Prof Callaway is particularly interested in the role of values such as integrity, respect and compassion, and their importance in workplace culture and wellbeing.

I am a Postdoctoral Research Fellow in Digital Health and Accredited Practising Dietitian (APD) interested in the prevention and management of noncommunicable diseases, especially obesity, across the lifecourse.

Through research, I aim to add health to life and equity to health by changing policies and practices to reduce the impact of obesity.

My research program aims to forge a new nexus across dietetics, digital health and public health to improve healthy weight. In my Postdoctoral Fellowship, I have established a new evidence base that supports precision public health approaches to the prevention and management of obesity, including innovate methods of public health surveillance that can use data from sources such as electronic medical records. I trained as a Paediatric Dietitian and have experience as a clinician-researcher working in Queensland's healthcare system, specifically in preventing and managing childhood obesity via clinical, community, and public health programs.

I have used epidemiology, public health informatics, action research, co-design, and ethnographic methods to generate new knowledge in obesity and digital health. I was awarded my PhD (UQ) in November 2020, which developed and validated i-PATHWAY, a clinical model to predict childhood obesity from the first 1,000 days to help guide its prevention. This research was the first of its kind in Australia and uncovered new evidence for risk factors for childhood obesity that are evident from the early years.

At The University of Queensland (UQ), I am a member of the Queensland Digital Health Centre, located within the Centre for Health Services Research (Faculty of Medicine). I established and currently Co-Chair the UQ Digital Health HDR Cohort, which provides research mentorship and support to ~20 PhD, MPhil and Honours research students.

Our team partners closely with multiple healthcare and research organisations across Australia to innovate and translate obesity research into practice, including Health and Wellbeing Queensland (public health and prevention of chronic diseases), Queensland Health (healthcare system) and the Digital Health Cooperative Research Centre (digital health research). I hold an Honorary Appointment with Health and Wellbeing Queensland, and an Affiliate Research Fellow position with the Faculty of Medicine (UQ) to help bridge the gap between obesity research and practice.

Dr Carroll completed his doctorate in Neuroscience at the University of Queensland in 2001. He was awarded an Isaac Walton Killam Memorial Scholarship to pursue postdoctoral studies at the University of Alberta in 2002, before accepting a position as a Lecturer in Human Motor Control at the University of New South Wales in 2003. He joined the School of Human Movement Studies as a Senior Lecturer in July 2007.

Dr Carroll’s research interests lie in the broad field of integrative human physiology. His work spans the fields of exercise science and integrative neuroscience, with a focus on determining how the central nervous system is reorganised as a consequence of motor learning and exercise. He has a specific interest in the area of strength training. Dr Carroll’s research involves the application of electro-physiological techniques such as Transcranial Magnetic Stimulation (TMS), peripheral nerve stimulation, and electromyography (EMG) in experiments involving human subjects. The ultimate purpose of his work is to generate basic knowledge that will lead to the development of exercise protocols that yield maximal benefits for rehabilitation and injury prevention. His work has been funded by the Australian Research Council (ARC) since 2004.

Dr. Gary Chan is a NHMRC Emerging Leadership Fellow at the National Centre for Youth Substance Use Research. His principal research interest lies in the field of substance misuse prevention and the application of cutting-edge statistical method for longitudinal analysis and causal inference. His recent publications have been focused on polysubstance use (including alcohol, tobacco and cannabis) profiles in adolescent populations, examinations of urban-rural differences in substance use, and the epidemiology of alcohol, tobacco and cannabis use. He collaborates extensively with leading researchers in major national and international institutes, including the University of Washington, Murdoch Children's Research Institute, University of Melbourne, and University College London. He has also served as a consultant at the United Nations Office of Drugs and Crime to improve exisitng methods for monitoring global trends of illicit substance production, trafficking and use. This work has made significant impact on how global data will be collected, and these new data will be used by the United nations and many national governments to inform drug policy decision making. He is a Deputy Statistical and Methodology Editor for the journal Addiction.

Dr. Chan is also a statistical advisor at the School of Psychology, providing statistical advice to academic staff and RHD students. Since 2016, he has also delivered several advanced statistcal workshops at the School on R and statistical modelling.

Associate Professor Fiona Charlson is a NHMRC Research Fellow at the Queensland Centre of Mental Health Research and School of Public Health, University of Queensland. She is a psychiatric epidemiologist and health services researcher with strong experience in addressing some of the most challenging global mental health research questions. Her research utilises a wide range of highly-specialised research skills, from traditional qualitative and quantitative research methods to new and innovative methods aimed at breaking down barriers to progress in the field. She has been a core member of the Mental Disorders and Illicit Drug Use Research Group for the Global Burden of Disease Study since 2009 and is at the leading edge of research into the mental health impacts of climate change and leads the Social and Emotional wellbeing group of UQ’s Climate Change and Health Transdisciplinary Impact Research Network. Her technical expertise is highly sought after and has attracted collaboration requests and funding from a wide range of national and international stakeholders, including; Queensland Health, the World Health Organization, the Institute for Health Metrics and Evaluation (University of Washington), US National Institutes of Health, Alan Flisher Centre for Public Mental Health (University of Cape Town) and various organisations in low- and middle-income countries.

• My academic qualifications include a PhD in Neurosciences, an MSc in Biochemistry and Molecular Biology, and a Bachelor of Medicine.
• I have initiated and managed multiple projects to develop novel therapeutics for neurological disorders, including: 1) Developing a nanoparticle-based siRNA delivery system for the treatment of Huntington’s disease (ARC project; as Postdoctoral Research Fellow). 2) Examining the treatment effects of intravenous immunoglobulin (IVIg) on epilepsy (Advance Queensland Women’s Academic Fund; as Sole Investigator). 2) Examining the effectiveness of three neuroinflammation modulatory agents on traumatic brain injury and epilepsy through randomised controlled preclinical trials (Seed projects sponsored by industry partners: VivaZome Therapeutics, Implicit Bioscience, and Innate Immunotherapeutics; as Co-investigator). 3) Developing treatment strategies to prevent the development of epilepsy after severe traumatic brain injury and identifying medical imaging biomarkers to evaluate the risk of epilepsy post-injury (two U.S. Department of Defense, Congressionally Directed Medical Research Programs; as Co-investigator). 4) Developing exosomal therapy for traumatic brain injury (Cooperative Research Centres Projects (CRC-P) Grant with two research groups from academic institutions and three pharmaceutical companies; as Principal Investigator).

Dr Hsin-Fang Chung is an epidemiologist and Research Fellow at the Australian Women and Girls’ Health Research Centre, School of Public Health. She is also an adjunct Collaborative Researcher at the Gunma University Initiative for Advanced Research (GIAR), Gunma University (2024-). Prior to this, Hsin-Fang completed her PhD on lifestyle and genetic risk factors of diabetic complications at UQ in 2015. She has a multidisciplinary educational background, spanning nursing, nutrition, public health, and epidemiology, and has worked in clinical and non-clinical sectors. Chung held UQ Research Stimulus Fellowship (2021-2022) and UQ Promoting Women Fellowship (2022).

Dr Chung has a track record of applying quantitative and modelling skills in women's health epidemiology. She has published more than 45 peer-reviewed publications and two book chapters. Hsin-Fang’s research focuses on women’s reproductive history (i.e., menarche, menstrual disorders, endometriosis, fertility issues, pregnancy complications, and menopause) in relation to chronic diseases in later life, particularly cardiovascular disease and type 2 diabetes. She uses high-quality data pooling from multiple epidemiological, cohort, and data-linkage studies in the InterLACE consortium to tackle critical knowledge gaps and inform practice and policy to develop long-term monitoring strategies for women with adverse reproductive histories. Her research pays particular attention to priority groups, including women from culturally and linguistically diverse communities.

Julie Cichero, PhD is a clinician (SLP), researcher and research professional with more than 25 years clinical and research experience into eating, drinking and swallowing problems (dysphagia). She has made significant contributions to the evidence base for standardised terminology for texture modified food and thick liquids, diagnostic use of swallow-respiratory sounds, characterisation of thick fluids and complexities associated with medication management in dysphagia. Recognised nationally and internationally, Julie is a consultant to professional societies, government organisations, academia, boards and healthcare organisations. As Foundation Co-Chair of IDDSI (Global) for a decade, Julie co-led development of the IDDSI Framework, an initiative to reduce food-related choking risk in vulnerable populations. The IDDSI Framework is used in more than 50 countries around the world.

An ecologist by training – I hold a B.Sc. (Hons) in Marine Ecology from the University of North Carolina, Wilmington and a Ph.D. in Ecological Modelling from Griffith University. I am broadly interested in exploring new ways to (1) understand how natural communities are formed and (2) predict how they will change over time. As an Amplify Fellow at UQ, my current research focuses on developing computational tools and adapting techniques from epidemiology and statistical forecasting to study how organisms and ecosystems respond to environmental change. This work is being applied to investigate natural dynamics for a range of natural systems including host-parasite interactions, wildlife populations and veterinary diseases.

I am an active member of the R community and have written and/or maintain several popular R packages. For example, I’m a lead developer on the MRFcov package for multivariate conditional random fields analyses. I also wrote the mvgam R package for fitting dynamic Generalised Additive Models to analyse and forecast multivariate ecological time series, and I regularly provide training seminars and workshops to help researchers learn techniques in ecological data analysis.

I am currently seeking Honours and PhD candidates with interests and/or skills in veterinary epidemiology, spatial / spatiotemporal modeling and quantitative ecology.

From 2020 Andrew has led research development at the Tess Cramond Pain and Research Centre (Royal Brisbane and Women's Hospital). Topics including clinical outcome measures, service evaluation and strategic planning, clinical trials employing pain education, opioid management, quantitative sensory testing and medical procedures. Current and recent projects include:

• Initiating the Pelvic Exenteration Pain Management Research Collaboration in 2024: A multidisciplinary community of clinicians and researchers at the Tess Cramond Pain and Research Centre, the Royal Prince Alfred Hospital, the Royal Brisbane and Women's Hospital, and the STARS Hospital, to study how the quality of life can be improved for people who have pelvic organs and tissues removed to manage cancer.
• Collaboration with the Institute of Urban Indigenous Health, to embed multidisciplinary research and quality improvement in the co-design and implementation of collaborative care between the TCPRC- IUIH, at the Moreton Aboriginal and Torres Strait Islander Community Health Service in Caboolture through 2023-2024.
• Contributing to the non-surgical pain management stream for the NHMRC-NIHR Collaborative Research Grant, for a multicentre RCT on the clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: Short: FusiOn veRsus bEst coNServatIve Care (the FORENSIC trial)
• The LIDOPAIN RCT in 2023: Lidocaine Infusion Dose Optimisation for Pain After Injury to Nerves, was a double-blind placebo-controlled pilot feasibility study for lidocaine infusions, with comprehensive pre-post evaluation of patient questionnaires and sensory testing profiles, to identify which patients do and to not respond to this infusion. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382966&isReview=true
• Advisor for Phoebe Ng, oral thesis defense 2024: Adolescent idiopathic scoliosis: Insights into health profile and paraspinal muscle activation.
• Advisor for Fraser Labrom, thesis awarded 2023: Three dimensional analysis of adolescent idiopathic scoliosis during growth.
• Collaboration with UQ RECOVER Injury Research Centre have
  • Currently completing a project funded by the RBWH Foundation, to examine small nerve fibre expression acutely and subacutely after motor vehicle accident, as a marker associated with the transition from acute to chronic pain.
  • Developed a chatbot for providing pain education for children and for adults,
  • Investigated the validity of phone apps for measuring the 6-minute walk test in people with persistent pain.
• Locally at the Tess Cramond Pain and Research Centre I co-lead annual projects for
  • quality improvement: UQ PHRM4071 student placement and Pain Medicine Trainee projects.
  • audit: ePPOC annual data reporting.
  • systematic reviews: UQ HRSS7801 group physiotherapy student project.

From 2004-2019 Andrew's PhD and postgraduate supervision as a lecturer in physiotherapy, focussed on how the brain controls posture and movement. This included studies of sitting, standing, stepping, squatting, pushing and postural control with low back pain and with adolescent idiopathic scoliosis. Extending understanding of postural control continues with colleagues at QUT Biomechanics and Spine Research Group (Prof Peter Pivonka, Maree Izatt and Assoc Prof Paige Little), the UQ Schools of ITEE (Dr Pauline Pounds) and SBMS Motor Control and Pain laboratory (Assoc Prof Kylie Tucker), and with Curtin University / UWA Raine cohort study (Prof Leon Straker).

David Cliff was Professor of Occupational Health and Safety in Mining and Director of MISHC from 2011 to 2016. In January 2017 he was appointed Professor of Risk and Knowledge Transfer, reverting to Professor of Occupational Health and Safety in Mining in 2018. His primary role is providing education, applied research and consulting in health and safety in the mining and minerals processing industry. He has been at MISHC over fifteen years.

Previously David was the Safety and Health Adviser to the Queensland Mining Council, and prior to that Manager of Mining Research at the Safety In Mines Testing and Research Station. In these capacities he has provided expert assistance in the areas of health and safety to the mining industry for over twenty three years. He has particular expertise in emergency preparedness, gas analysis, spontaneous combustion, fires and explosions, including providing expert testimony to the Moura No.2 Warden’s inquiry, the Hazelwood Mine Fire Inquiry and the Pike River Royal Commission. In recent times he has also devoted a lot of energy to fitness for duty issues particularly fatigue management. He has been a member of the organising committee for the level one emergency exercises in Queensland underground coal mines since their inception in 1998. He has also attended or provided assistance in over 30 incidents at mines. He has developed expertise in the development of Trigger Action Response Plans.

David has also extensive experience in providing training and education in OHS in mining to in many countries.

He has published widely in the area of occupational health and safety in mining including not just the physical hazards but also on the processes for the effective management of these issues. Examples of this include reviews of the annual safety performance report for the Queensland Department of Natural Resources and Mines and assistance to the Mine Safety Advisory Council of NSW in developing Health Management Plans (HMP) and key performance indicators for HMP.

In recent years he has collaborated closely with Nikky LaBranche researching respirable dust particularly coal dust and silica.

Anton is a mixed methods researcher with primary expertise in qualitative research methods. He is currently a Senior Research Fellow in the UQ Poche Centre for Indigenous Health at the University of Queensland.

Anton's primary interest is in working in partnership with Aboriginal community-controlled health services to co-design, implement and evaluate intervention strategies, and develop more practical and effective models of embedding evaluation into their delivery of services and programs. His work in this area focuses on participatory qualitative research with staff and patients of Aboriginal community-controlled health services to improve the acceptability of interventions and optimise their potential effectiveness.

Anton has previously worked in a research role with the Institute for Urban Indigenous Health and as a senior lecturer in the School of Public Health at the University of Queensland. Following completion of his PhD in 2008, he was awarded a National Health & Medical Research Council postdoctoral research fellowship which he undertook at the National Drug and Alcohol Research Centre, University of NSW.

Professor Tracy Comans, a UQ Amplify Fellow at the Centre for Health Services Research, University of Queensland, and an Adjunct Research Fellow at the Royal Brisbane and Women’s Hospital, is renowned for her innovative application of economics in multifaceted health services contexts. Her pioneering work involves the creation of comprehensive models that extend beyond traditional economic models, enabling a broader assessment of benefits and costs.

In addition to her model development, Professor Comans applies these economic models to explore the cost-effectiveness of various health care interventions. She spearheads and cultivates health services research with a particular focus on older individuals, allied health, and rehabilitation services.

With a solid academic foundation in both physiotherapy and economics (Hons), Professor Comans brings a unique perspective to her research. Her clinical background as a physiotherapist, specializing in aged care, dementia, and rehabilitation, further enriches her work. Her expertise was recognized with a NHMRC Boosting Dementia Fellowship, which she held from 2017 to 2021.

Currently, Professor Comans is making significant strides in measuring the quality of care for older individuals. This work holds substantial potential for impacting the health and aged care industry. As our population ages, the demand for high-quality health care services tailored to the needs of older individuals is escalating. Despite this, there is a lack of agreement on what constitutes quality care for this demographic, and existing measures may not fully capture the aspects of care most important to them. Professor Comans’ work is instrumental in addressing this critical issue.

Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” (link) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in Review of Income and Wealth, Health Economics, Journal of Health Economics, Journal of Risk and Insurance, Geneva Papers on Risk and Insurance, Accident Analysis and Prevention, Journal of Law and Medicine, Journal of Clinical Epidemiology, European Journal of Health Economics, International Journal of Health Economics and Finance, Social Science and Medicine, Economic Papers, Economic Analysis and Policy, Journal of Transport Economics and Policy, Labour Economics, Economics and Human Biology as well as in a range of clinical journals, including Lancet.

Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks.

His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland.

Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

Jason Connor is a Professor of Clinical and Health Psychology in the Discipline of Psychiatry and Founding Director of the National Centre for Youth Substance Use Research (2008 - 2014, 2017+) at The University of Queensland.

Professor Connor is a clinical psychologist by training and a Fellow of the Australian Psychological Society (APS). He has specialist membership in the APS Health and Clinical Colleges. Jason commenced his academic career after being awarded a National Health and Medical Research Council (NH&MRC) doctoral scholarship (PhD, 2002) for research into substance use disorders.

Since moving from full-time clinical practice to academia, he has successfully combined teaching responsibilities with research.

Professor Connor has won an Australian award for excellence in university teaching.

He has published over 290 peer reviewed journal papers, books and book chapters. Professor Connor has received $23 million in research funding as Chief Investigator and currently leads $2.3 million in Catergor 1 external research grants.

Professor Connor's main research focus is substance use disorders. Research areas include substance use assessment and treatment, genetic markers of alcohol and nicotine dependence, measurement of alcohol craving, novel psychological models of problem drinking and the prevention of youth substance abuse. He is a consultant for the World Health Organisation (substance use) and member of the Federal Government’s Alcohol & Drug Centres of Excellence Strategic Reference Group, which is tasked with guiding the evidenced based policy for substance use in Australia.

Professor Connor has received awards for his research (NH&MRC Career Development Fellow; Australian Psychological Society Early Career Research Award) and service to the profession of psychology (Australian Psychological Society Health College Award of Distinction).

In addition to his academic roles, he has an appointment with Queensland Health and continues to offer clinical services.

Examples of recent publications:

Connor, J.P., Stjepanović, D., Le Foll, B., Hoch, E., Budney A., Hall, W.D. (2021) Cannabis use and cannabis use disorders. NATURE REVIEWS: DISEASE PRIMERS, 25;7(1) 16.

Ahmed, F., Boogaerts, T., Bowes, D.A., van Nuijs, A.L.N., Covaci, A., Hall, W., Connor, J.P., Thomas, K.V. (2024). Enhanced estimation of the prevalence of treated mental health disorders by wastewater-based epidemiology, NATURE MENTAL HEALTH 2, 345–347.

Connor, J.P., Stjepanović, D., Budney A., Le Foll, B., Hall, W.D. (2022) Clinical Management of Cannabis Withdrawal. ADDICTION,117(7):2075-2095.

Symons, M., Feeney, G.F.X., Gallagher, M.R., Young, R.M., Connor, J.P. (2020). Predicting alcohol dependence treatment outcomes: a prospective comparative study of clinical psychologists versus 'trained' machine learning models. ADDICTION, 115(11) 2164-2175

Connor, J.P., Hall, W.D. (2018). Thresholds for safer alcohol use might need lowering. LANCET, 391(10129), 1460-1461.

Connor, J.P., Haber, P.S., Hall, W.D. (2016). Alcohol Use Disorders. LANCET, 387(10022), 988-98.

Connor, J. P. Hall, W.D. (2015). Alcohol burden in low-income and middle-income countries. LANCET, 386(10007), 1922-4.

A well-presented, self-motivated and professional MSc graduate in sport sciences with a strong passion for human sensorimotor control and kinesiology of musculoskeletal system. Samuele conducted research about neurological impairments of upper limb sensorimotor control, together with investigations of sport/rehab exercise biomechanics. His current research is focusing on context-dependent modulation of rapid visuomotor responses of plausible subcortical origin. His research has showed that there are meaningful subcortical contributions to human reaching behavior.

Louise Conwell, MBBS(HonsI) PGCert MEd (Dundee) FRACP PhD, is a Senior Staff Specialist (Eminent) in Paediatric Endocrinology and Diabetes at the Queensland Children’s Hospital, Children’s Health Queensland. Louise’s work as a Paediatric Endocrinologist involves working in a multi-disciplinary team to care for neonates, children and adolescents with a wide spectrum of endocrinologist disorders.

Louise commenced as Head of the Children's Health Queensland Clinical Unit, School of Clinical Medicine, University of Queensland in June 2018. She is also the Acting Head of the Mayne Academy of Paediatrics, Faculty of Medicine, University of Queensland.

Louise is a graduate of the University of Queensland and trained in paediatrics at the Mater Children’s Hospital, Brisbane. She then trained in paediatric endocrinology and diabetes at the Royal Children’s Hospital in Brisbane while completing a PhD at the University of Queensland. Louise undertook a post-specialty Clinical Fellowship at the Division of Endocrinology and Metabolism, The Hospital for Sick Children, Uinversity of Toronto, Ontario, Canada.

Louise has a particular interest in Congenital Hyperinsulinism and other beta-cell disorders including Type 1 and Monogenic Diabetes. Her other clinical interest areas include Disorders of Sexual Differentiation and endocrine oncology. Louise currently works in the endocrine oncology clinic connected with the After Cancer Therapy Service at the Queensland Children's Hospital, Brisbane.

Louise's PhD was in the field of insulin resistance and cardiovascular risk in obese children and adolescents. Louise remains active in clinical research with grant attainment, particularly in the field of beta-cell disorders.

Louise is a member of national and international professional bodies. She is the current President (past Secretary) of the Australasian Paediatric Endocrine Group, serving on Council since November 2017. She also has past or present committee memberships including the Scientific Organising Committee, Clinical Fellows School Committee, Diabetes Committee, the Disorders of Sexual Differentiation Committee, Registry Committee, Research Grant Committee, Thyroid Working Group and the Cancer Survivorship Working Group).

Louise also has engagement with stakeholder groups, particularly Congenital Hyperinsulinism International. She is co-chair of the Congenital Hyperinsulinism International Collaborative Research Network - Care Guidelines and Centres of Excellence.

Louise represents the Australasian Paediatric Endocrine Group on the International Consortium of Pediatric Endocrinology (ICPE) and is co-chair of ICPE's subcommittee, the Intersociety Clinical Guidelines Committee (ICGC).

Louise has an interest in Evidence-Based Medicine, with authorship in the Cochrane Database of Systematic Reviews. She is co-Chair of the International Clinical Guidelines Committee of the International Consortium of Paediatric Endocrinology.

A further interest area includes medical ecucation, completing a Postgraduate Certificate in Medical Education (University of Dundee, Scotland) in 2017. She has facilitated and contributed to a wide range of educational activities for a variety of student, professional and community stakeholder groups in a range of contexts. Louise is a supervisor of basic and advanced paediatric trainees of the Royal Australasian College of Physicians. Other roles include Supervisor, Reader and Examiner for Postgraduate Higher Degree Research students of the University of Queensland and other academic institutions in Australia.